WO1997046682A3 - Polynucleotides from human adult PBMC encoding secreted proteins - Google Patents

Polynucleotides from human adult PBMC encoding secreted proteins Download PDF

Info

Publication number
WO1997046682A3
WO1997046682A3 PCT/US1997/009865 US9709865W WO9746682A3 WO 1997046682 A3 WO1997046682 A3 WO 1997046682A3 US 9709865 W US9709865 W US 9709865W WO 9746682 A3 WO9746682 A3 WO 9746682A3
Authority
WO
WIPO (PCT)
Prior art keywords
secreted proteins
polynucleotides
encoding secreted
human adult
adult pbmc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1997/009865
Other languages
French (fr)
Other versions
WO1997046682A2 (en
Inventor
Kenneth Jacobs
John M Mccoy
Lisa A Racie
Adward R Lavallie
David Merberg
Maurica Treacy
Cheryl Evans
Michael Bowman
Vikki Spaulding
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Original Assignee
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute LLC filed Critical Genetics Institute LLC
Priority to AU35686/97A priority Critical patent/AU3568697A/en
Priority to EP97932156A priority patent/EP0915971A2/en
Priority to JP10500876A priority patent/JP2000515726A/en
Priority to CA002257243A priority patent/CA2257243A1/en
Publication of WO1997046682A2 publication Critical patent/WO1997046682A2/en
Publication of WO1997046682A3 publication Critical patent/WO1997046682A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)

Abstract

The invention provides a clone D 147-17 isolated from a human adult PBMC cDNA library comprising polynucleotides encoding secreted proteins using methods selective for cDNAs encoding secreted proteins.
PCT/US1997/009865 1996-06-07 1997-06-06 Polynucleotides from human adult pbmc encoding secreted proteins Ceased WO1997046682A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU35686/97A AU3568697A (en) 1996-06-07 1997-06-06 Polynucleotides from human adult pbmc endocing secreted proteins
EP97932156A EP0915971A2 (en) 1996-06-07 1997-06-06 Polynucleotides from human adult pbmc endocing secreted proteins
JP10500876A JP2000515726A (en) 1996-06-07 1997-06-06 Polynucleotide derived from adult PBMC encoding secreted protein
CA002257243A CA2257243A1 (en) 1996-06-07 1997-06-06 Polynucleotides from human adult pbmc encoding secreted proteins

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65922496A 1996-06-07 1996-06-07
US08/659,224 1996-06-07
US08/867,677 1997-06-02

Publications (2)

Publication Number Publication Date
WO1997046682A2 WO1997046682A2 (en) 1997-12-11
WO1997046682A3 true WO1997046682A3 (en) 1998-03-12

Family

ID=24644568

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US1997/009878 Ceased WO1997046683A2 (en) 1996-06-07 1997-06-06 Polynucleotides encoding secreted proteins
PCT/US1997/009865 Ceased WO1997046682A2 (en) 1996-06-07 1997-06-06 Polynucleotides from human adult pbmc encoding secreted proteins

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/US1997/009878 Ceased WO1997046683A2 (en) 1996-06-07 1997-06-06 Polynucleotides encoding secreted proteins

Country Status (5)

Country Link
EP (1) EP0910638A2 (en)
JP (2) JP2000515726A (en)
AU (2) AU3568697A (en)
CA (1) CA2256522A1 (en)
WO (2) WO1997046683A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7005509B1 (en) 1995-02-17 2006-02-28 Incyte Corporation Chemokine PANEC-1 polynucleotides and compositions and methods related thereto
US7265201B1 (en) 1995-06-23 2007-09-04 Millennium Pharmaceuticals, Inc. Human chemotactic cytokine
WO1999035158A1 (en) * 1998-01-07 1999-07-15 Human Genome Sciences, Inc. 36 human secreted proteins
US6875741B2 (en) 1998-09-02 2005-04-05 Renuka Pillutla Insulin and IGF-1 receptor agonists and antagonists
US7173005B2 (en) 1998-09-02 2007-02-06 Antyra Inc. Insulin and IGF-1 receptor agonists and antagonists
WO2001072771A2 (en) * 2000-03-29 2001-10-04 Dgi Biotechnologies, L.L.C. Insulin and igf-1 receptor agonists and antagonists
CN111334469A (en) * 2020-03-27 2020-06-26 郑州鲲鹏健康科技有限公司 PBMC (peripheral blood mononuclear cell) in-vitro 3D (three-dimensional) methylcellulose agarose hydrogel culture medium and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
CALLARD R E ET AL: "AIMS OF THE BOOK", CYTOKINE FACTSBOOK, 1994, CALLARD R E;GEARING A J H, pages 2/3, 31 - 38, 64/65, 75/76, 97/98, 148 - 151, 252/253, XP002039160 *
JACOBS K ET AL: "A NOVEL METHOD FOR ISOLATING EUKARYOTIC CDNA CLONES ENCODING SECRETED PROTEINS", JOURNAL OF CELLULAR BIOCHEMISTRY - SUPPLEMENT, vol. 21A, 10 March 1995 (1995-03-10), pages 19, XP002027246 *
K. A. JACOBS ET AL: "A genetic selection for isolating cDNAs encoding secreted proteins", GENE., vol. 198, 1 October 1997 (1997-10-01), AMSTERDAM NL, pages 289 - 296, XP002045919 *
L. HILLIER ET AL: "The WashU-Merck EST project. ym65b04.r1 Homo sapiens cDNA clone 163759 5'", EMBL DATABASE ENTRY HS129166 ; ACCESSION NUMBER H14129, 11 July 1995 (1995-07-11), XP002046553 *
L. HILLIER ET AL: "The WashU-Merck EST project. zk50e05.s1 Soares pregnant uterus NbHPU Homo sapiens cDNA clone 486272 3'", EMBL DATABASE ENTRY HSA44020; ACCESSION NUMBER AA044020, 7 September 1996 (1996-09-07), XP002046554 *
M. YOKOYAMA-KOBAYASHI ET AL: "A signal sequence detection system using secreted protease activity as an indicator", GENE., vol. 163, 1995, AMSTERDAM NL, pages 193 - 196, XP002046435 *
TASHIRO K ET AL: "SIGNAL SEQUENCE TRAP: A CLONING STRATEGY FOR SECRETED PROTEINS AND TYPE I MEMBRANE PROTEINS", SCIENCE, vol. 261, 30 July 1993 (1993-07-30), pages 600 - 603, XP000673204 *

Also Published As

Publication number Publication date
AU3568697A (en) 1998-01-05
JP2000515726A (en) 2000-11-28
WO1997046682A2 (en) 1997-12-11
CA2256522A1 (en) 1997-12-11
WO1997046683A2 (en) 1997-12-11
EP0910638A2 (en) 1999-04-28
JP2001501455A (en) 2001-02-06
AU3380497A (en) 1998-01-05
WO1997046683A3 (en) 1998-05-07

Similar Documents

Publication Publication Date Title
WO1998007859A3 (en) Secreted proteins and polynucleotides encoding them
EP2374876A3 (en) Therapy for alpha-galactosidase A deficiency
AU6844696A (en) Recombinant clone selection system
WO1999057132A8 (en) Secreted proteins and polynucleotides encoding them
WO1998033916A3 (en) Secreted proteins and polynucleotides encoding them
WO1998042741A3 (en) Secreted proteins and polynucleotides encoding them
WO1997048799A3 (en) Polynucleotides from human fetal brain encoding secreted proteins
WO1997046682A3 (en) Polynucleotides from human adult PBMC encoding secreted proteins
AU7689696A (en) Dna sequence encoding the tumor suppressor ing1
WO1998055614A3 (en) Secreted proteins and polynucleotides encoding them
WO1998027205A3 (en) Secreted proteins and polynucleotides encoding them
HU9903292D0 (en) Remedy for autoimmune diseases
WO1999058642A3 (en) Secreted proteins and polynucleotides encoding them
WO1997048801A3 (en) Polynucleotides encoding secreted proteins
WO1997040069A3 (en) Secreted proteins and polynucleotides encoding them
WO1998037094A3 (en) Secreted proteins and polynucleotides encoding them
WO1997040151A3 (en) Secreted proteins and polynucleotides encoding them
WO1998030589A3 (en) Secreted proteins and polynucleotides encoding them
WO1997038084A3 (en) Polynucleotides derived from a pbmc cdna library encoding secreted proteins
WO1998040404A3 (en) Secreted proteins and polynucleotides encoding them
WO1999058684A3 (en) Compounds from moraxella catarrhalis
AU3398697A (en) Polynucleotides encoding secreted proteins from human pbmc
AU6653298A (en) Cdna encoding nucleoside transporter
WO1998056909A3 (en) Secreted proteins and polynucleotides encoding them
WO1998041539A3 (en) Secreted proteins and polynucleotides encoding them

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP MX

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT.BUL.53/97, UNDER INID(54)"TITLE",REPLACE THE EXISTING TEXT BY"POLYNUCLEOTIDES FROM HUMAN ADULT PBMC ENCODING SECRETED PROTEINS"

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2257243

Country of ref document: CA

Ref country code: CA

Ref document number: 2257243

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1997932156

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1997932156

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1997932156

Country of ref document: EP